These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34027801)
21. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2. Ayachit AG; Reddy LU; Joshi S; Ayachit GS Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674 [TBL] [Abstract][Full Text] [Related]
22. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A; Petrou P; Douvali M; Ntouraki A; Vergados I; Georgalas I; Markomichelakis N Retina; 2011 May; 31(5):871-9. PubMed ID: 21358461 [TBL] [Abstract][Full Text] [Related]
23. LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2. Toygar O; Guess MG; Youssef DS; Miller DM Retina; 2016 Nov; 36(11):2150-2157. PubMed ID: 27258671 [TBL] [Abstract][Full Text] [Related]
24. Ranibizumab treatment for choroidal neovascularization secondary to causes other than age-related macular degeneration with good baseline visual acuity. Erol MK; Ozdemir O; Coban DT; Ceran BB; Bulut M Semin Ophthalmol; 2014 Mar; 29(2):108-13. PubMed ID: 24409939 [TBL] [Abstract][Full Text] [Related]
25. Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization. Çoban Karataş M; Yılmaz G; Yüce Sezen A; Sarıtürk Ç Turk J Ophthalmol; 2022 Feb; 52(1):45-49. PubMed ID: 35196839 [TBL] [Abstract][Full Text] [Related]
26. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab. Yang HS; Kim JG; Kim JT; Joe SG Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429 [TBL] [Abstract][Full Text] [Related]
27. Choroidal neovascularization associated with butterfly-shaped pattern dystrophy - a case report. Świerczyńska M; Danikiewicz-Zagała M; Sedlak L; Nowak-Wąs M; Wyględowska-Promieńska D Rom J Ophthalmol; 2023; 67(2):185-190. PubMed ID: 37522013 [TBL] [Abstract][Full Text] [Related]
28. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials. Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG; Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282 [TBL] [Abstract][Full Text] [Related]
30. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
31. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group. Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078 [TBL] [Abstract][Full Text] [Related]
32. Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy. Chen YC; Chen SN Br J Ophthalmol; 2020 Nov; 104(11):1561-1566. PubMed ID: 32051140 [TBL] [Abstract][Full Text] [Related]